Ibrunat 140 mg

Ibrunat 140 mg Capsule (containing Ibrutinib) is a targeted cancer therapy, specifically a Bruton's tyrosine kinase (BTK) inhibitor used for blood cancers like CLL and MCL. It works by binding permanently to the BTK protein, interrupting signals that allow malignant B-cells to survive and multiply, effectively reducing tumor size and slowing disease progression.